Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Stock Report

| More

GlaxoSmithKline Pharmaceuticals Limited announces results for the quarter ended September 30, 2019

Posted On: 2019-10-22 22:01:47

GlaxoSmithKline Pharmaceuticals Limited today declared its financial results for the quarter ended 30th September 2019. Revenue for the quarter came in at Rs.873 crores with a growth of 8%. Profit After Tax (including exceptional items) at Rs.503 crores recorded a growth of 399%.

Exceptional items recognised in the quarter includes divestment of the company's land at Thane for a net consideration of Rs.552 crores, pursuant to receipt of all statutory and regulatory approvals from the concerned authorities. Exceptional items also include the financial impact of product recall detailed below:

GSK has been contacted by regulatory authorities regarding the detection of NOMA in ranitidine products. Based on the information received and correspondence with regulatory authorities, GSK made the decision to suspend the release, distribution and supply of all dose forms of ranitidine hydrochloride products to all markets, including India, as a precautionary action pending the outcome of ongoing tests and investigations. GSK manufactures Ranitidine Hydrochloride IP Tablets 150 mg and 300 mg (Zinetac) for supply to the Indian market.

Further to additional information received and as a precautionary action, GSK made the decision to initiate a voluntary pharmacy/retail level recall of the Zinetac products above from the Indian market. GSK is continuing with investigations into the potential source of the NOMA. These investigations include continued engagement with our API suppliers. Patient safety remains our utmost priority and we are taking this issue very seriously.

Commenting on the results, A. Vaidheesh, Managing Director, GlaxoSmithKline Pharmaceuticals Limited said, "Our global Innovation, Performance & Trust (IPT) strategy underpinned by our culture, has guided investment of our resources in focus therapies which is showing encouraging results with our promoted brands recording +20% growth this quarter. We continue to see the annualizing effect of discontinued tailend brands. Adjusting for this our underlying sales growth is 16% supported by strong volume growth of 11%.

We continue to drive improved operational efficiencies reflecting in our EBITOA margin improving by 2 percentage points, to 22%. We have also seen some early success on the launch of Nucala (Mepolizumab) which is a humanised monoclonal antibody and indicated as an add-on treatment for severe refractory eosinophilic asthma in adult patients.

GSK's consistent commitment to being gender inclusive has been recognised externally. We have been identified among India's Best Workplaces for Women 2019, by the Great Place to Work® Institute and have also, once again, featured as 100 Best Companies for Women in India by Working Mother & Avtar. Both these recognitions are based on feedback from our women colleagues, their engagement and perceptions and also from assessment of our existing policies and processes as benchmarked against the best in the industry."

Shares of GLAXOSMITHKLINE PHARMACEUTICALS LTD. was last trading in BSE at Rs.1469.15 as compared to the previous close of Rs. 1440.15. The total number of shares traded during the day was 17683 in over 1841 trades.

The stock hit an intraday high of Rs. 1505.9 and intraday low of 1430. The net turnover during the day was Rs. 25826734.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Info Edge (India) Limited announces Q2 FY20 results

Sundaram Finance Q2 Net Profit at Rs. 269crores

U GRO Capital Ltd announces Q2, H1 FY20 results

Welspun Corp Ltd bags contracts for supply of 147 KMT of pipes

Polyplex Corporation Ltd's arm commissions PET Film Plant in Indonesia

J. B. Chemicals & Pharmaceuticals Ltd. board approves buyback at Rs. 440

Info Edge (India) Ltd Board declares Interim Dividend of Rs. 2.50 for 2019-20

Vidhi Specialty Food Ingredients Ltd board declares 2nd interim dividend of Rs. 0.20

Adani Gas Ltd consolidated Q2 PAT up at Rs. 120.06 crores

Cords Cable Industries Ltd posts PAT of Rs. 2.22 crores in Q2 FY20

YUKEN India Ltd consolidated net profit falls in Q2

Marksans Pharma Ltd consolidated Q2 net profit at Rs. crores

Godawari Power & Ispat Ltd consolidated Q2 PAT drops to Rs. 49.39 crores

Bayer Cropscience Ltd reports net profit of Rs. 169.8 crores in Q2

Rossell India Ltd Q2 net profit surges to Rs. 28.17 crores

Ram Ratna Wires Ltd Q2 consolidated PAT soars to Rs. 7.10 crores

Kamat Hotels India Ltd consolidated net profit at Rs. 2.44 crores in Q2

AIA Engineering Ltd Q2 consolidated PAT climbs to Rs. 151.99 crores

Rajapalayam Mills Ltd posts consolidated PAT of Rs. 29.96 crores in Q2

Vidhi Specialty Food Ingredients Ltd reports Q2 net profit of Rs. 8.50 crores

GP Petroleums Ltd posts PAT of Rs. 5.39 crores in Q2

ABBOTT India Ltd reports surge in Q2 PAT to Rs. 178.33 crores

Morganite Crucible India Ltd Q2 PAT lower at Rs. 2.67 crores

Mohit Paper Mills Ltd posts net profit of Rs. 0.60 crore in Q2

Vinyl Chemicals India Ltd Q2 net profit at Rs. 2.61 crores

Crest Ventures Ltd consolidated PAT at Rs. 14.88 crores in Q2 FY20

Venky's India Ltd Q2 PAT up YoY at Rs. 13.59 crores

Q2 consolidated PAT of Polyspin Exports Ltd up QoQ

Lokesh Machines Ltd posts Rs. 0.73 crore net profit in Q2 FY20

Polymechplast Machines Ltd Q2 net profit at Rs. 0.31 crore

Empire Industries Ltd posts net profit of Rs. 8.15 crores in Q2

Daikaffil Chemicals India Ltd Q2 net profit at Rs. 0.09 crore

Bombay Cycle & Motor Agency Ltd posts PAT of Rs. 0.75 crore in Q2

Sundaram Finance Ltd reports consolidated Q2 PAT rises to Rs. 187.08 crores

The Phoenix Mills Limited delivers strong operational performance for H1FY20

Metropolis Healthcare announces H1FY20 results

Mirchi revenues fall 7%, Solutions grow 33.9%

Tamilnadu Petroproducts Ltd continues impressive performance in Q2 FY20

Maithan Alloys Ltd updates on auction of Impex Metal & Ferro Alloys Ltd

HGS announces Q2 earnings for FY2020

ATUL Auto Ltd declares interim dividend of Rs. 1.50 for 2019-20

ADF Foods Ltd board declares interim dividend of Rs. 1.50 for 2019-20

Sandur Manganese & Iron Ores Ltd Board approves Dividend for 2019-20

Balmer Lawrie & Company Ltd board recommends 1:2 bonus issue

Shares of Apollo Pipes list on NSE

TCS Enhances Smart City Solution to Help Urban Leaders Deliver Better Citizen Experiences

Jindal Stainless Limited reports Q2FY20 PAT at Rs 52 crore

Embassy Office Parks REIT Announces Second Quarter FY 2019-20 Results

Royal Orchid Hotels Ltd Consolidated Revenue at Rs. 50.65 Cr in Q2

GIC Re records y-o-y growth of 11.6 % in Gross Premium







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019